Diffusion Pharmaceuticals News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Diffusion Pharmaceuticals Inc DFFN NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
0.00 0.0% 0.8825 0.00 0.00 0.00 0.8825 04:12:39
more quote information »

Recent News

Date Time Source Heading
7/14/20209:01IHNWFeaturedPAOG Announces Management Takeover and Medical Cannabis Strategy Revitalization
7/07/202016:39EDGARCurrent Report Filing (8-k)
7/07/202008:00GLOBEDiffusion Pharmaceuticals Files IND for International Phase..
6/18/202016:53EDGARStatement of Changes in Beneficial Ownership (4)
6/18/202016:53EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202016:38EDGARCurrent Report Filing (8-k)
6/12/202012:19EDGARCurrent Report Filing (8-k)
6/11/202008:00GLOBEDiffusion Pharmaceuticals Files Clinical Trial Application..
6/11/202006:00EDGARNotice of Effectiveness (effect)
6/08/202016:49EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
6/03/202017:26EDGARSecurities Registration Statement (s-1/a)
6/01/202016:41EDGARCurrent Report Filing (8-k)
6/01/202008:00GLOBEDiffusion Pharmaceuticals Regains Compliance with NASDAQ..
5/29/202017:23EDGARSecurities Registration Statement (s-1)
5/27/202016:58EDGARSmall Company Offering and Sale of Securities Without..
5/26/202016:46EDGARCurrent Report Filing (8-k)
5/26/202008:00GLOBEDiffusion Pharmaceuticals Receives Accelerated FDA Response..
5/20/202017:28EDGARCurrent Report Filing (8-k)
5/20/202017:23EDGARCurrent Report Filing (8-k)
5/20/202013:00GLOBEDiffusion Pharmaceuticals Inc. Announces Closing of $12.0..
5/20/202008:00GLOBEDiffusion Pharmaceuticals Expands Clinical Trial Program of..
5/19/202017:30EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
5/18/202009:05GLOBEDiffusion Pharmaceuticals Inc. Announces $12 Million..
5/15/202016:33EDGARSmall Company Offering and Sale of Securities Without..
5/13/202016:53EDGARSecurities Registration: Employee Benefit Plan (s-8)
5/11/202016:59EDGARCurrent Report Filing (8-k)
5/11/202016:11GLOBEDiffusion Pharmaceuticals Reports First Quarter 2020..
5/11/202016:03EDGARQuarterly Report (10-q)
5/08/202016:42EDGARCurrent Report Filing (8-k)
5/06/202009:06EDGARCurrent Report Filing (8-k)
5/05/202008:00GLOBEDiffusion Pharmaceuticals Announces FDA Accelerated Review..
4/29/202016:29EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/29/202016:29EDGARProxy Statement (definitive) (def 14a)
4/29/202008:45EDGARCurrent Report Filing (8-k)
4/27/202008:00GLOBEDiffusion Pharmaceuticals Announces Pre-IND Submission to..
4/17/202017:27EDGARProxy Statement - Notice of Shareholders Meeting..
4/01/202016:42EDGARCurrent Report Filing (8-k)
4/01/202008:00GLOBEDiffusion Pharmaceuticals Evaluating TSC Against Acute..
3/24/202016:41EDGARCurrent Report Filing (8-k)
3/24/202016:05GLOBEDiffusion Pharmaceuticals Anticipates Enrollment in its..
3/18/202018:35GLOBECORRECTION -- Diffusion Pharmaceuticals Reports 2019..
3/18/202017:23EDGARCurrent Report Filing (8-k)
3/17/202016:10GLOBEDiffusion Pharmaceuticals Reports 2019 Financial Results..
3/17/202016:07EDGARAnnual Report (10-k)
3/12/202008:00GLOBEDiffusion Pharmaceuticals Announces Retirement of Chief..
2/14/202015:56EDGARAmended Statement of Ownership (sc 13g/a)
2/14/202011:23EDGARAmended Statement of Ownership (sc 13g/a)
2/07/202008:30GLOBEDiffusion Pharmaceuticals Receives European Patent Related..
2/06/202016:40EDGARCurrent Report Filing (8-k)
1/30/202016:56EDGARStatement of Changes in Beneficial Ownership (4)
1/30/202016:55EDGARStatement of Changes in Beneficial Ownership (4)
See more news about this stock »

Your Recent History
Diffusion ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.